Citizens cuts Alkami Technology stock price target on slowing growth

Alkami Technology reported Q1 2026 revenue of $126.1 million, up 29% year over year and slightly above consensus, while adjusted EBITDA of $22.3 million also beat estimates. However, annual recurring revenue of $493.6 million came in just below expectations and growth slowed as the company lapped its MANTL acquisition, with EPS at -$0.09 versus the $0.18 forecast. Citizens lowered its price target to $23 from $28 while keeping a Market Outperform rating, and the stock fell about 1% after hours.

Analysis

The market is pricing ALKT as if the quarter was a clean miss, but the more important signal is that customer acquisition is still running ahead of expectations while profitability is finally approaching a self-funding profile. In software, the first derivative matters less than whether the installed base can keep compounding without escalating sales intensity; here, the gap between user growth and recurring revenue suggests the issue is mix and acquisition timing, not demand collapse. That usually means the stock can recover quickly if management proves the integration drag from MANTL is temporary rather than structural.

The real second-order question is competitive. If ALKT is taking share in digital banking despite slower reported organic ARR, that pressures smaller core banking and fintech vendors that lack a similar distribution footprint, while benefiting bank clients who can delay vendor overhauls and negotiate better pricing. The risk is that a weaker growth print gives competitors room to attack on valuation and product breadth over the next 1-2 quarters, especially if banks interpret the slowdown as evidence that the growth story has peaked.

Consensus appears too fixated on near-term growth deceleration and not enough on the operating leverage inflection. A company that is close to turning profitable can rerate sharply once the market believes EBITDA can grow faster than revenue; that transition often matters more than a one-quarter ARR miss. The bearish case only really gets traction if organic growth stays pinned near the high-teens for multiple quarters, because then the model shifts from “integration drag” to “maturing product,” which would justify a much lower multiple.

The setup is therefore more about timing than direction: the stock may remain range-bound for weeks, but the skew improves if management can show stable net retention and no step-up in customer churn. A one-month window is too short to prove the thesis; the next 1-2 quarters are the catalyst horizon. If another print shows EBITDA expanding while user adds remain strong, the market likely re-rates the stock before the fundamentals fully show up in trailing numbers.

Key Decisions for Investors

• Consider a tactical long ALKT position over the next 1-2 quarters, sized for volatility, on the thesis that profitability inflection will matter more than the organic growth deceleration once integration noise fades; risk/reward improves if the stock remains depressed below prior trading ranges.
• For better-defined downside, buy ALKT call spreads 2-3 months out rather than common stock if you expect a rerating on guidance stabilization; this limits theta decay while preserving upside if management re-anchors growth expectations.
• If already long, hedge with a short basket of lower-quality fintech/software names that are more exposed to valuation compression from slowing growth, using ALKT as the relative-quality leg; the trade works if the market starts rewarding earnings durability over headline growth.
• Avoid shorting ALKT outright into the next print unless you have conviction that organic growth will remain stuck in the high-teens for multiple quarters; the near-term catalyst path favors sharp upside squeezes on any evidence of margin discipline.
• Watch for a pair-trade opportunity long ALKT / short a slower-growing digital banking peer if the next quarter confirms operating leverage; that creates a cleaner expression of execution quality rather than a broad sector beta bet.